Macrogenics MGNX
NASDAQ MGNX
$4.34 +0.09 (+2.12%)
As of: Sep 4, 2026 · 12:52 PM EDT

Macrogenics (MGNX) Profit After Tax (2012 - 2026)

Macrogenics (MGNX) posted quarterly Profit After Tax of -$36.8 million for Q1 2026, up 10.39% year-over-year from -$33.3 million in Q1 2025, and down 159.78% quarter-over-quarter from -$14.2 million in Q4 2025.

Analysis

Macrogenics (MGNX) Profit After Tax (2012 - 2026) Analysis & Trends

Macrogenics (MGNX) has reported Profit After Tax for 15 consecutive years, with -$36.8 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Profit After Tax rose 10.39% year-over-year to -$36.8 million; the TTM figure through Mar 2026 stood at -$70.4 million (down 26.09% YoY), while the FY2025 annual figure was -$74.6 million, down 11.45% from the prior year.
  • Profit After Tax declined to -$36.8 million in Q1 2026 per MGNX's latest filing, from -$14.2 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $57.5 million in Q2 2023 and bottomed at -$66.4 million in Q1 2022.
  • Historically, Profit After Tax has averaged -$18.1 million across 5 years, with a median of -$36.3 million in 2025.
  • On a YoY basis, Profit After Tax climbed as much as 239.14% in 2023 and fell as far as 459.65% in 2023.
  • Macrogenics' Profit After Tax stood at $12.8 million in 2022, then tumbled by 459.65% to -$46.0 million in 2023, then jumped by 66.53% to -$15.4 million in 2024, then gained by 8.14% to -$14.2 million in 2025, then tumbled by 159.78% to -$36.8 million in 2026.
  • Business Quant data shows MGNX's Profit After Tax at -$36.8 million in Q1 2026, -$14.2 million in Q4 2025, and $16.8 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.62 Bn 131.77 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.73 Bn 77.73 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 63.53 Bn 58.35 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.23 Bn 53.09 Bn 52.00 Mn -782.00 Mn
5 Revolution Medicines 44.05 Bn 44.05 Bn - -644.37 Mn
6 BeOne Medicines 40.03 Bn 34.93 Bn 1.53 Bn 237.01 Mn
7 Alnylam Pharmaceuticals 35.50 Bn 32.19 Bn 992.69 Mn 164.49 Mn
8 Royalty Pharma 28.52 Bn 27.68 Bn - 81.49 Mn
9 Insmed 27.46 Bn 26.30 Bn 358.27 Mn -16.62 Mn
10 Macrogenics 274.09 Mn 160.19 Mn - -69.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -69.64 Mn
Mar 31, 2026 -36.77 Mn
Dec 31, 2025 -14.16 Mn
Sep 30, 2025 16.83 Mn
Jun 30, 2025 -42.72 Mn
Mar 31, 2025 -41.04 Mn
Dec 31, 2024 -15.42 Mn
Sep 30, 2024 56.35 Mn
Jun 30, 2024 -55.66 Mn
Mar 31, 2024 -52.19 Mn
Dec 31, 2023 -46.07 Mn
Sep 30, 2023 17.59 Mn
Jun 30, 2023 57.47 Mn
Mar 31, 2023 -38.01 Mn
Dec 31, 2022 12.85 Mn
Sep 30, 2022 -24.81 Mn
Jun 30, 2022 -41.30 Mn
Mar 31, 2022 -66.44 Mn
Dec 31, 2021 -58.08 Mn
Sep 30, 2021 -52.89 Mn